Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
8,816,189
-
Share change
-
-117,397
-
Total reported value
-
$111,962,000
-
Price per share
-
$12.70
-
Number of holders
-
42
-
Value change
-
-$1,557,200
-
Number of buys
-
17
-
Number of sells
-
13
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2016
As of 31 Mar 2016,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,816,189 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, LLC, Aisling Capital LLC, BB BIOTECH AG, PERCEPTIVE ADVISORS LLC, GOLDMAN SACHS GROUP INC, AWM Investment Company, Inc., EVENTIDE ASSET MANAGEMENT, LLC, and Rock Springs Capital Management LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.